The Future of Allergy Care Starts at Home

Join us in revolutionizing how 100M+ Americans manage their allergies

Market Opportunity

100M+ Sufferers

Growing number of U.S. allergy sufferers with increasing severity

First-to-Market

No consumer-friendly home pollen testing exists — until now

Recurring Revenue

Quarterly subscription model creates predictable, scalable income

Retail Opportunity

Massive pharmacy and retail distribution potential

Institutional Flywheel

Provider Network creates rapid clinical adoption

IP Protection

Patent pending hardware + proprietary analysis pipeline

Scalable Business Model

Direct-to-Consumer (D2C)

Primary revenue through e-commerce platform with one-time purchases and quarterly subscriptions. Low customer acquisition cost via digital marketing and organic search.

B2B Clinical Network

Partner clinics drive high-value referrals while benefiting from improved patient outcomes. Multiple partnership models create flexibility and scalability.

Retail Distribution

Phase 2 expansion into pharmacy chains and specialty retailers provides massive distribution leverage with established consumer trust.

Request Investor Information

Interested in learning more? Fill out the form below and we'll be in touch.